Page 719 - Hematology_ Basic Principles and Practice ( PDFDrive )

607.e4 Part VII Hematologic Malignancies

149. Pearson HA, Spencer RP, Cornelius EA: Functional asplenia in sickle- 175. Powars DR: Sickle cell anemia: beta s-gene-cluster haplotypes as prog-
cell anemia. N Engl J Med 281:923, 1969. nostic indicators of vital organ failure. Semin Hematol 28:202, 1991.
150. Pearson HA, Gallagher D, Chilcote R, et al: Developmental pattern 176. Russell MO, Goldberg HI, Hodson A, et al: Effect of transfusion
of splenic dysfunction in sickle cell disorders. Pediatrics 76:392, therapy on arteriographic abnormalities and on recurrence of stroke in
1985. sickle cell disease. Blood 63:162, 1984.
151. Zarkowsky HS, Gallagher D, Gill FM, et al: Bacteremia in sickle 177. Adams RJ, Brambilla D: Discontinuing prophylactic transfusions used
hemoglobinopathies. J Pediatr 109:579, 1986. to prevent stroke in sickle cell disease. N Engl J Med 353:2769, 2005.
152. Leikin SL, Gallagher D, Kinney TR, et al: Mortality in children and 178. Walters MC, Storb R, Patience M, et al: Impact of bone marrow
adolescents with sickle cell disease. Cooperative Study of Sickle Cell transplantation for symptomatic sickle cell disease: an interim report.
Disease. Pediatrics 84:500, 1989. Multicenter investigation of bone marrow transplantation for sickle cell
153. Greene JR, Polk OD, Castro O: Fulminant pneumococcal sepsis in an disease. Blood 95:1918, 2000.
adult with sickle-cell anemia. N Engl J Med 311:674, 1984. 179. Chapman N, Huxley R, Anderson C, et al: Effects of a perindopril-
154. Robinson MG, Watson RJ: Pneumococcal meningitis in sickle-cell based blood pressure-lowering regimen on the risk of recurrent stroke
anemia. N Engl J Med 274:1006, 1966. according to stroke subtype and medical history: the PROGRESS Trial.
155. Wilimas JA, Flynn PM, Harris S, et al: A randomized study of outpa- Stroke 35:116, 2004.
tient treatment with ceftriaxone for selected febrile children with sickle 180. Pegelow CH, Adams RJ, McKie V, et al: Risk of recurrent stroke in
cell disease. N Engl J Med 329:472, 1993. patients with sickle cell disease treated with erythrocyte transfusions.
156. Syrogiannopoulos GA, McCracken GH, Jr, Nelson JD: Osteoarticular J Pediatr 126:896, 1995.
infections in children with sickle cell disease. Pediatrics 78:1090, 1986. 181. Liu JE, Gzesh DJ, Ballas SK: The spectrum of epilepsy in sickle cell
157. Kurtzman GJ, Gascon P, Caras M, et al: B19 parvovirus replicates in anemia. J Neurol Sci 123:6, 1994.
circulating cells of acutely infected patients. Blood 71:1448, 1988. 182. Castro O, Brambilla DJ, Thorington B, et al: The acute chest syndrome
158. Powars D, Wilson B, Imbus C, et al: The natural history of stroke in in sickle cell disease: incidence and risk factors. The Cooperative Study
sickle cell disease. Am J Med 65:461, 1978. of Sickle Cell Disease. Blood 84:643, 1994.
159. Sarnaik SA, Lusher JM: Neurological complications of sickle cell 183. Godeau B, Schaeffer A, Bachir D, et al: Bronchoalveolar lavage in adult
anemia. Am J Pediatr Hematol Oncol 4:386, 1982. sickle cell patients with acute chest syndrome: value for diagnostic
160. Switzer JA, Hess DC, Nichols FT, et al: Pathophysiology and treatment assessment of fat embolism. Am J Respir Crit Care Med 153:1691, 1996.
of stroke in sickle-cell disease: present and future. Lancet Neurol 5:501, 184. Vichinsky EP, Styles LA, Colangelo LH, et al: Acute chest syndrome in
2006. sickle cell disease: clinical presentation and course. Cooperative Study
161. Koshy M, Thomas C, Goodwin J: Vascular lesions in the central of Sickle Cell Disease. Blood 89:1787, 1997.
nervous system in sickle cell disease (neuropathology). J Assoc Acad 185. Styles LA, Aarsman AJ, Vichinsky EP, et al: Secretory phospholipase
Minor Phys 1:71, 1990. A(2) predicts impending acute chest syndrome in sickle cell disease.
162. Tuohy AM, McKie V, Manci EA, et al: Internal carotid artery occlusion Blood 96:3276, 2000.
in a child with sickle cell disease: case report and immunohistochemical 186. Gladwin MT, Sachdev V, Jison ML, et al: Pulmonary hypertension as
study. J Pediatr Hematol Oncol 19:455, 1997. a risk factor for death in patients with sickle cell disease. N Engl J Med
163. Hoppe C, Klitz W, Noble J, et al: Distinct HLA associations by stroke 350:886, 2004.
subtype in children with sickle cell anemia. Blood 101:2865, 2003. 187. Vichinsky EP: Pulmonary hypertension in sickle cell disease. N Engl J
164. Stockman JA, Nigro MA, Mishkin MM, et al: Occlusion of large Med 350:857, 2004.
cerebral vessels in sickle-cell anemia. N Engl J Med 287:846, 1972. 188. Collins FS, Orringer EP: Pulmonary hypertension and cor pulmonale
165. Hoppe C, Klitz W, Cheng S, et al: Gene interactions and stroke risk in in the sickle hemoglobinopathies. Am J Med 73:814, 1982.
children with sickle cell anemia. Blood 103:2391, 2004. 189. Adedeji MO, Cespedes J, Allen K, et al: Pulmonary thrombotic
166. Suzuki J, Takaku A: Cerebrovascular “moyamoya” disease. Disease arteriopathy in patients with sickle cell disease. Arch Pathol Lab Med
showing abnormal net-like vessels in base of brain. Arch Neurol 20:288, 125:1436, 2001.
1969. 190. Haque AK, Gokhale S, Rampy BA, et al: Pulmonary hypertension in
167. Ueki K, Meyer FB, Mellinger JF: Moyamoya disease: the disorder and sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases.
surgical treatment. Mayo Clin Proc 69:749, 1994. Hum Pathol 33:1037, 2002.
168. Goldstein LB, Adams R, Alberts MJ, et al: Primary prevention of 191. Machado RF, Anthi A, Steinberg MH, et al: N-terminal pro-brain
ischemic stroke: a guideline from the American Heart Association/ natriuretic peptide levels and risk of death in sickle cell disease. JAMA
American Stroke Association Stroke Council: cosponsored by the 296:310, 2006.
Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working 192. Castro O, Hoque M, Brown BD: Pulmonary hypertension in sickle
Group; Cardiovascular Nursing Council; Clinical Cardiology Council; cell disease: cardiac catheterization results and survival. Blood 101:1257,
Nutrition, Physical Activity, and Metabolism Council; and the Quality 2003.
of Care and Outcomes Research Interdisciplinary Working Group. 193. Machado RF, Barst RJ, Yovetich NA, et al: Hospitalization for pain in
Circulation 113:e873, 2006. patients with SCD treated with sildenafil for elevated TRV and low
169. Schatz J, Finke RL, Kellett JM, et al: Cognitive functioning in children exercise capacity. Blood 118:855, 2011.
with sickle cell disease: a meta-analysis. J Pediatr Psychol 27:739, 2002. 194. Powars D, Weidman JA, Odom-Maryon T, et al: Sickle cell chronic
170. Schatz J, White DA, Moinuddin A, et al: Lesion burden and cognitive lung disease: prior morbidity and the risk of pulmonary failure. Medi-
morbidity in children with sickle cell disease. J Child Neurol 17:891, cine (Baltimore) 67:66, 1988.
2002. 195. Samuels MP, Stebbens VA, Davies SC, et al: Sleep related upper airway
171. Adams RJ, McKie VC, Hsu L, et al: Prevention of a first stroke by obstruction and hypoxaemia in sickle cell disease. Arch Dis Child
transfusions in children with sickle cell anemia and abnormal results 67:925, 1992.
on transcranial Doppler ultrasonography. N Engl J Med 339:5, 1998. 196. Banerjee S, Owen C, Chopra S: Sickle cell hepatopathy. Hepatology
172. Miller ST, Macklin EA, Pegelow CH, et al: Silent infarction as a risk 33:1021, 2001.
factor for overt stroke in children with sickle cell anemia: a report from 197. Zakaria N, Knisely A, Portmann B, et al: Acute sickle cell hepatopathy
the Cooperative Study of Sickle Cell Disease. J Pediatr 139:385, 2001. represents a potential contraindication for percutaneous liver biopsy.
173. Kirkham FJ, Hewes DK, Prengler M, et al: Nocturnal hypoxaemia and Blood 101:101, 2003.
central-nervous-system events in sickle-cell disease. Lancet 357:1656, 198. Rennels MB, Dunne MG, Grossman NJ, et al: Cholelithiasis in patients
2001. with major sickle hemoglobinopathies. Am J Dis Child 138:66, 1984.
174. Pegelow CH, Colangelo L, Steinberg M, et al: Natural history of blood 199. Ware RE, Kinney TR, Casey JR, et al: Laparoscopic cholecystectomy
pressure in sickle cell disease: risks for stroke and death associated with in young patients with sickle hemoglobinopathies. J Pediatr 120:58,
relative hypertension in sickle cell anemia. Am J Med 102:171, 1997. 1992.